We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 1
graphic measures of cardiac mechanics (20), ultrasono-
FIGURE 1 graphic measurement of carotid artery intima-media thick-
Cardiovascular (CV) risk according to level of insulinemia. ness (21), and measurement of endothelium-dependent leg The polycystic ovary syndrome (PCOS) itself carries more CV blood flow (22). Therefore, although unproved, it seems risk than control, even at equivalent insulin levels. Hyperin- reasonable to suppose that risk factors predict CV outcome sulinemic PCOS patients have even more CV risk factors. among women with PCOS. These differences are statistically significant when corrected for body mass index (P!.004) and differ between the PCOS BMI versus Insulin Resistance and Excess groups as well as between each PCOS group and control Risk (P#.05). The mean insulin levels were 52.0, 53.7, and 181.3 pmol/L for controls, normoinsulinemic PCOS women, and The aggregation of CV risk factors in PCOS patients has hyperinsulinemic PCOS women, respectively. been previously observed (1, 3, 9, 12, 23, 24), but the relative contributions of BMI and insulin levels remain controversial. Studies using obesity or insulin as univariate predictors of CV risk have found statistically significant relationships (9, 12, 25), but few studies have examined the interaction di- rectly. After correction for BMI, our data show significant relationships of insulin level with waist circumference and lipid levels but not with waist-to-hip ratio, fasting glucose level, or blood pressure. Table 4 shows that among the hyperinsulinemic PCOS patients, CV risk factors are up to five times as prevalent as among the normoinsulinemic PCOS patients. Among women with PCOS, CV risks have been reported to vary according to degree of obesity: Lean PCOS women are reported to have fewer lipid abnormalities (26), and obese PCOS women have abnormalities in blood pressure and blood glucose levels, whereas their lean counterparts do not (12). Undiagnosed type 2 diabetes mellitus is very prevalent, and the rate of conversion to frank type 2 dia- betes mellitus is at least fivefold that of obese nonPCOS women (27). In healthy subjects, a threshold effect of obesity on insu- lin resistance has been described, with insulin resistance appearing at a BMI "26.8 (28). Patients with PCOS have higher insulin levels than controls across the range of BMI (Figure 2) (29), and both lean and obese women with PCOS have been shown to be insulin resistant (30). This suggests that PCOS itself confers insulin resistance, with the added effect of obesity. Despite this interdependence, we were able to demonstrate that insulin resistance correlated with CV risk even after correction for BMI. This supports the argument Mather. Hyperinsulinemia in PCOS. Fertil Steril 2000. that insulin resistance per se is important in determining cardiovascular risk and suggests that the role of obesity in records for women diagnosed with PCOS at least 18 years determining risk is mediated at least in part through its earlier and reported a standardized mortality ratio for isch- augmentation of insulin resistance. emic heart disease of 1.4 (95% CI, 0.75–2.4, P ! not significant) on the basis of 13 ischemic heart disease deaths Hyperinsulinemia and Metabolic among 59 total deaths in 786 women. Nonepidemiologic Abnormalities in PCOS data provide some evidence of an excess of vascular disease Hyperinsulinemia in PCOS has been found to correlate in women with PCOS. Women undergoing cardiac catheter- with low HDL and high triglyceride levels (12), as was seen ization demonstrated a correlation between the extent of in our patients. This combination is frequently associated coronary atherosclerosis and the presence of morphologi- with small, dense LDL particles, which carry greater cardio- cally polycystic ovaries (19). Abnormalities in preclinical vascular risk than more buoyant LDL particles (31). We also measures of vascular disease among women with PCOS observed an increase in total and LDL cholesterol levels that have also been demonstrated, using Doppler ultrasono- was proportional to the insulin level among the PCOS
154 Mather et al. Hyperinsulinemia and CV risk in PCOS Vol. 73, No. 1, January 2000
Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women With the Polycystic Ovary Syndrome- A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS)